Beyond the Powerhouse – Unveiling Hidden Influence of Mitochondria on Reproductive Health and Fertility

Mitochondria's role in male fertility

Mitochondrial functionality, particularly the maintenance of an intact mitochondrial membrane potential, is a prerequisite for optimal sperm function and overall semen quality. Mitochondria supply the ATP necessary for sperm motility, with the dynein protein’s ATPase activity confirming the essential role of ATP in driving flagellar movement. In addition to powering motility, mitochondria contribute to key reproductive processes such as sperm capacitation and fertilisation.^[7]

Mitochondrial quality is preserved through tightly regulated quality control mechanisms, including fission and fusion processes, collectively referred to as mitochondrial dynamics. These dynamic events allow mitochondrial populations to mix their contents, ensuring functional homogeneity and adaptability to metabolic demands. Mitochondrial dynamics are particularly critical during spermatogenesis and meiosis, where energy needs and metabolic states fluctuate rapidly.^[8,9]

Additionally, mitophagy, the selective degradation of damaged mitochondria via autophagy,^[10] serves as a vital process to maintain cellular homeostasis and prevent the accumulation of dysfunctional mitochondria in developing germ cells.

The coordination of mitochondrial dynamics and turnover is intricately linked to the metabolic requirements of germ cells as they navigate the compartmentalised architecture of the seminiferous epithelium.^[11] Any disruption to these finely tuned processes, whether from genetic disorders, metabolic diseases, or environmental toxins, can lead to mitochondrial dysfunction and consequent infertility in males.

Reactive oxygen species (ROS) formation occurs primarily in mitochondrial complexes I and II residing in the mid-piece of spermatozoa. Although ROS plays a role in normal cellular signalling, an imbalance, characterised by excessive ROS production alongside insufficient antioxidant defences, can be detrimental to sperm cells.^[12] Due to the high concentration of polyunsaturated fatty acids in sperm membranes, excessive ROS readily induces lipid peroxidation, resulting in impaired spermatogenesis, mitochondrial dysfunction, and apoptosis.^[13] These effects significantly compromise male fertility.

Mitochondrial DNA (mtDNA) is especially vulnerable to oxidative damage, given its proximity to the electron transport chain and lack of protective histones. Oxidative stress not only disrupts mitochondrial integrity but also leads to reduced sperm motility, lower fertilising capacity, and increased susceptibility to programmed cell death.^[14] Protective mechanisms, such as the expression of mitochondrial uncoupling protein 2 (UCP2), help modulate ROS levels and maintain sperm quality under stress.^[15] However, when mitochondrial function is severely impaired or mtDNA accumulates mutations, there is often an increase in mtDNA copy number alongside reduced mtDNA integrity, both of which are associated with poor sperm quality.^[16]

Such mitochondrial impairments can manifest clinically as asthenozoospermia (reduced sperm motility), oligospermia (low sperm count), and teratozoospermia (abnormal sperm morphology), ultimately contributing to male infertility.^[17-20]

Mitochondria's role in female fertility

Among all cell types, the oocyte contains the highest number of mitochondria and mitochondrial DNA (mtDNA) copies per cell.^[21] These organelles are vital for fulfilling the substantial energy requirements of the oocyte, particularly during processes such as meiotic maturation, fertilisation, and early embryonic development. During oocyte growth and maturation, mtDNA copy number increases dramatically to support the energy needs of subsequent developmental stages.^[22] Proper mitochondrial function is essential for oocyte maturation and the acquisition of developmental competence.^[23] Disruptions in mitochondrial dynamics or deviations in mtDNA content and expression are associated with diminished ovarian reserve, impaired oocyte quality, and poor reproductive outcomes. Dysfunctional mitochondria or abnormal mtDNA expression are directly linked to conditions such as ovarian insufficiency and implantation failure. Oocytes harbouring deleterious mtDNA mutations are often eliminated via follicular atresia, a process believed to contribute to reduced ovarian reserve in some individuals.^[24]

With age, the accumulation of mtDNA mutations in oocytes contributes significantly to ovarian ageing and a decline in fertility.^[25,26] A low mtDNA copy number within oocytes has been associated with fertilisation failure and aberrant embryonic development.^[21,27,28]

To address mitochondrial dysfunction and improve oocyte quality, especially in advanced age or those experiencing recurrent in vitro fertilization (IVF) failure, various mitochondrial transfer techniques are under investigation. These include both autologous and heterologous approaches, though the optimal strategy remains under refinement.^[26,29] In pigs, mitochondrial transfer from developmentally competent oocytes has been shown to enhance oocyte competence significantly.^[30] Similarly, the transfer of mitochondria derived from surrounding follicular cells has shown promise in improving oocyte quality in bovine and human models. However, the efficacy and safety of mitochondrial transfer techniques are not yet fully established, and additional research is needed to determine their long-term outcomes and clinical viability.^[31]

Mitochondrial epigenetics

Mitochondrial DNA (mtDNA), though structurally distinct from nuclear DNA, being circular, maternally inherited, and histone-free, undergoes epigenetic-type modifications similar to those seen in the nucleus. These include DNA methylation, hydroxymethylation, and alterations in nucleoid-associated protein structure, all of which influence mitochondrial transcription and replication.^[32,33] Such modifications are critical, as they directly affect mitochondrial functions like energy production, redox balance, and apoptosis, processes fundamental to gametogenesis and early embryonic development. ^[25]

Factors such as ageing, excess body weight, and metabolic disorders can compromise mtDNA integrity in oocytes, leading to mutations, a reduced mtDNA copy number, and impaired ATP synthesis. These mitochondrial defects may result in abnormal spindle formation and diminished embryo viability.^[34,35] Additionally, mitochondrial dysfunction in granulosa cells has been shown to alter mitochondrial gene expression and biogenesis, impairing folliculogenesis and ovulatory processes.^[32]

Emerging evidence suggests that assisted reproductive technologies (ART) may influence mitochondrial epigenetic landscapes, potentially exerting long-term effects on the health of offspring.^[35] In sperm, epigenetic alterations in mtDNA, such as methylation patterns, oxidative stress-induced damage, and dysregulation of non-coding RNAs, have been associated with male infertility conditions like asthenozoospermia and oligo-astheno-zoospermia, both of which impair fertilisation capacity.^[36]

Although paternal mitochondria are typically eliminated after fertilisation, their epigenetic state prior to this event may still influence embryonic development through retrograde signalling. This mitochondria-to-nucleus communication can modify nuclear gene expression by altering DNA methylation, histone modifications, and non-coding RNA activity in germ cells, thereby disrupting transcriptional regulation.^[37,38]

Environmental stressors, including toxins, poor nutrition, and metabolic imbalances, can exacerbate mitochondrial dysfunction, adversely impacting fertility in both males and females.^[39]

Current research is increasingly focused on therapeutic interventions aimed at restoring mitochondrial function. These include the use of antioxidants such as Coenzyme Q10, sirtuin (SIRT) pathway modulators, and mitochondrial transfer techniques, all of which hold promise for enhancing reproductive outcomes.^[35,40] Figure 1 shows the involvement of mitochondria in sperm physiology, oocyte maturation, and early embryonic development. The mitochondrial production of ATP and the electron transport chain have roles in sperm motility, capacitation, and meiotic maturation, while overproduction of ROS due to ageing, stress, and metabolic disease damages mtDNA, causing apoptosis and impairing embryo development and fertilisation.

Close

Figure 1:

Schematic representation of mitochondrial role in gamete functioning, fertilisation, and embryo development. ETC: electron transport chain, ATP: adenosine triphosphate, IMM: inner mitochondrial membrane, MMP: mitochondrial membrane potential, mtDNA: mitochondrial DNA, ROS: reactive oxygen species, GVBD: germinal vesicle breakdown, LH: luteinising hormone

Export to PPT

Understanding the complex interplay between mitochondrial and nuclear epigenetics opens promising avenues for diagnosing, preventing, and treating infertility. As research in this area deepens, it may unlock targeted therapeutic strategies to improve reproductive health.

Clinical significance

From a clinical fertility perspective, mitochondrial integrity is central to oocyte quality. Age-related mitochondrial dysfunction, characterised by accumulated mtDNA mutations, reduced ATP production, altered calcium homeostasis, and oxidative stress, contributes directly to poor oocyte competence, increased aneuploidy, implantation failure, and miscarriage. This explains why advanced maternal age remains one of the strongest predictors of reduced IVF success and adverse reproductive outcomes.^[41]

Clinically, this understanding has led to novel therapeutic strategies, particularly mitochondrial replacement therapy (MRT). Techniques such as spindle transfer and pronuclear transfer allow replacement of defective mitochondrial cytoplasm while preserving the patient’s nuclear genome. This has dual significance: Prevention of transmission of mtDNA disorders, which otherwise have no curative treatment and can cause severe multisystem disease in offspring. Restoration of cytoplasmic competence in infertile patients, especially older women with repeated IVF failure, offering the possibility of genetically related but metabolically rejuvenated embryos. MRT represents a major clinical advancement aimed at preventing the transmission of mtDNA-based diseases and improving fertility outcomes. Techniques such as spindle transfer (ST), pronuclear transfer (PNT), and polar body transfer (PBT) enable the replacement of defective mitochondria while preserving the nuclear genetic identity of the parents. Another critical clinical implication lies in embryo viability and developmental programming. Even low levels of mitochondrial dysfunction can impair early embryonic metabolism, influencing blastocyst quality and long-term health. Experimental and preclinical studies demonstrate that minimising mtDNA carryover below disease thresholds (<2%) is achievable and likely clinically safe, reinforcing the feasibility of MRT as a preventive and therapeutic intervention in reproductive medicine.^[42] Finally, these insights reshape reproductive counselling and ethics. Mitochondria are not passive energy units but active determinants of fertility, inheritance, and offspring health. Clinicians must therefore integrate mitochondrial assessment, age-related mitochondrial decline, and emerging mitochondrial therapies into infertility management and genetic counselling.

Future direction

Future research must pivot from correlation to mechanistic causality, focusing on four interconnected pillars. First, the development of standardised, non-invasive mitochondrial biomarkers, such as cell-free mtDNA mutations in follicular fluid and sperm telomere-mtDNA copy number ratios, is essential for clinical adoption. Second, deciphering the precise bidirectional signalling between mitochondrial metabolites (e.g., acetyl-CoA, α-ketoglutarate) and nuclear epigenetic machinery during gametogenesis will identify novel therapeutic targets for epigenetic dysregulation. Third, advancing mitochondria-specific therapeutic delivery, including next-generation antioxidants (MitoQ analogues) and safe autologous mitochondrial transfer protocols, requires rigorous preclinical validation to ensure efficacy and long-term safety. Finally, longitudinal clinical studies must integrate these biomarkers and interventions to establish causative links between mitochondrial dysfunction, ART outcomes, and offspring health. This integrated approach will transition mitochondrial science from a diagnostic adjunct to a central pillar of personalised reproductive medicine, enabling targeted interventions that address the root causes of idiopathic infertility.